174 related articles for article (PubMed ID: 15686719)
21. Effect of prophylaxis with low-dose anti-thymocyte globulin on prevention of acute kidney allograft rejection.
Khosroshahi HT; Tubbs RS; Shoja MM; Ghafari A; Noshad H; Ardalan MR
Transplant Proc; 2008; 40(1):137-9. PubMed ID: 18261569
[TBL] [Abstract][Full Text] [Related]
22. Treatment of cardiac allograft rejection with intravenous corticosteroids.
Miller LW
J Heart Transplant; 1990; 9(3 Pt 2):283-7. PubMed ID: 2355284
[TBL] [Abstract][Full Text] [Related]
23. Antibody-mediated rejection: treatment alternatives and outcomes.
Singh N; Pirsch J; Samaniego M
Transplant Rev (Orlando); 2009 Jan; 23(1):34-46. PubMed ID: 19027615
[TBL] [Abstract][Full Text] [Related]
24. Severe cardiac allograft dysfunction without endomyocardial biopsy signs of cellular rejection: incidence and management.
Veiga Barreiro A; Crespo Leiro M; Doménech García N; Paniagua MJ; Vázquez Martul E; González Cuesta M; Ramírez C; Juffé Stein A; Castro Beiras A
Transplant Proc; 2004 Apr; 36(3):778-9. PubMed ID: 15110660
[TBL] [Abstract][Full Text] [Related]
25. Graft loss associated with late humoral rejection after renal transplantation.
Sun Q; Li L
Clin Transpl; 2006; ():521-5. PubMed ID: 18365417
[TBL] [Abstract][Full Text] [Related]
26. Tacrolimus rescue therapy for corticosteroid-resistant and polyclonal antibody-resistant kidney allograft rejections.
Naderi GH; Mehraban D; Ganji MR; Yahyazadeh SR; Latif AH
Urol J; 2009; 6(1):31-4. PubMed ID: 19241339
[TBL] [Abstract][Full Text] [Related]
27. Single dose of Rituximab plus plasmapheresis in an HIV patient with acute humoral kidney transplant rejection: a case report.
Moscoso-Solorzano GT; Baltar JM; Seco M; López-Larrea C; Mastroianni-Kirsztajn G; Ortega F
Transplant Proc; 2007 Dec; 39(10):3460-2. PubMed ID: 18089407
[TBL] [Abstract][Full Text] [Related]
28. The incidence of acute cellular rejection after lung transplantation: a comparative study of anti-thymocyte globulin and daclizumab.
Burton CM; Andersen CB; Jensen AS; Iversen M; Milman N; Boesgaard S; Arendrup H; Eliasen K; Carlsen J
J Heart Lung Transplant; 2006 Jun; 25(6):638-47. PubMed ID: 16730569
[TBL] [Abstract][Full Text] [Related]
29. Treatment of humoral rejection with rituximab.
Garrett HE; Groshart K; Duvall-Seaman D; Combs D; Suggs R
Ann Thorac Surg; 2002 Oct; 74(4):1240-2. PubMed ID: 12400781
[TBL] [Abstract][Full Text] [Related]
30. [Corticoid-resistant rejection and humoral rejection. The diagnostic criteria and therapeutic management].
Crespo Leiro MG; Portela Torrón F; Vázquez González N; Vázquez Rodríguez JM; Yebra Pimentel MT; González Cuesta M
Rev Esp Cardiol; 1995; 48 Suppl 7():77-85. PubMed ID: 8775821
[TBL] [Abstract][Full Text] [Related]
31. Avenues for acquired immune tolerance.
Wood KJ; Morris PJ
Semin Thorac Cardiovasc Surg; 1990 Apr; 2(2):189-97. PubMed ID: 2081227
[No Abstract] [Full Text] [Related]
32. Reversible myocardial hypertrophy induced by tacrolimus in a pediatric heart transplant recipient: case report.
Mano A; Nakatani T; Yahata Y; Kato T; Hashimoto S; Wada K; Ishibashi-Ueda H
Transplant Proc; 2009 Nov; 41(9):3831-4. PubMed ID: 19917396
[TBL] [Abstract][Full Text] [Related]
33. Relationship between bridging with ventricular assist device on rejection after heart transplantation.
Pamboukian SV; Costanzo MR; Dunlap S; Rayburn B; Westfall AO; You ZY; Hung E; McLeod M; Heroux A
J Heart Lung Transplant; 2005 Mar; 24(3):310-5. PubMed ID: 15737758
[TBL] [Abstract][Full Text] [Related]
34. One center's experience with antithymocyte globulin treatment for acute rejection in renal transplantation.
Colak T; Sevmiş S; Karakayali H; Moray G; Haberal M
Transplant Proc; 2008; 40(1):123-5. PubMed ID: 18261564
[TBL] [Abstract][Full Text] [Related]
35. Successful therapy with rituximab of refractory acute humoral renal transplant rejection: a case report.
Celik A; Saglam F; Cavdar C; Sifil A; Atila K; Sarioglu S; Bora S; Gulay H; Camsari T
Transplant Proc; 2008; 40(1):302-4. PubMed ID: 18261611
[TBL] [Abstract][Full Text] [Related]
36. Early recurrence of nephrotic syndrome (immunoglobulin m nephropathy) after renal transplantation successfully treated with combinations of plasma exchanges, immunoglobulin, and rituximab.
Westphal S; Hansson S; Mjörnstedt L; Mölne J; Swerkersson S; Friman S
Transplant Proc; 2006 Oct; 38(8):2659-60. PubMed ID: 17098031
[TBL] [Abstract][Full Text] [Related]
37. Is a single low-fixed dose of rituximab sufficient for treating acute humoral rejection after kidney transplantation?
Kamar N; Rostaing L
Transplantation; 2009 Jul; 88(1):142; author reply 142-3. PubMed ID: 19584695
[No Abstract] [Full Text] [Related]
38. Late acute cardiac allograft rejection: new therapeutic options?
Schweiger M; Wasler A; Prenner G; Tripolt M; Schwarz M; Tscheliessnigg KH
Transplant Proc; 2005 Dec; 37(10):4528-31. PubMed ID: 16387161
[TBL] [Abstract][Full Text] [Related]
39. Early rejection prophylaxis in heart transplantation: is cytolytic therapy necessary?
Renlund DG; O'Connell JB; Bristow MR
J Heart Transplant; 1989; 8(3):191-3. PubMed ID: 2661767
[No Abstract] [Full Text] [Related]
40. Graft mucormycosis in a renal allograft recipient.
Ahmad M
J Nephrol; 2005; 18(6):783-6. PubMed ID: 16358241
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
